Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Ambuja Cements Ltd. (ACEM:IN) PT Lowered to INR502 at Cantor Fitzgerald on Seasonal Softness
-
First Financial Bankshares (FFIN) PT Lowered to $34 at Cantor Fitzgerald on Lower Fee Income
-
East West Bancorp (EWBC) PT Lowered to $146 at Cantor Fitzgerald on Higher Non-Interest Expense
-
Cullen/Frost Bankers (CFR) PT Lowered to $167 at Cantor Fitzgerald on Lower Core Fee Income
-
Citizens Financial Group (CFG) PT Lowered to $78 at Cantor Fitzgerald on Higher Expenses, Lower Fee Income
-
BankUnited (BKU) PT Lowered to $52 at Cantor Fitzgerald on Lower Expected NIM
-
Anteris Technologies Global (AVR) Reiterated at Overweight by Cantor Fitzgerald on Clinical Case for DurAVR
-
Kura Oncology (KURA) Reiterated at Overweight by Cantor Fitzgerald After Webinar on KO-7246
-
Omeros (OMER) Reiterated at Overweight by Cantor Fitzgerald Ahead of Potential Catalyst
-
Sterling Construction (STRL) Reiterated at Overweight by Cantor Fitzgerald on Long-Term E-Infra Opportunity
-
Cantor Fitzgerald Starts Sol Gel Technologies Ltd. (SLGL) at Overweight
-
Verastem Oncology prices $250M stock and warrant offering
-
Strive plans IPO of 15% preferred stock to fund bitcoin buys
-
Freshworks (FRSH) Reiterated at Overweight by Cantor Fitzgerald on Agreement to Acquire Torii
-
CytomX Therapeutics (CTMX) Reiterated at Overweight by Cantor Fitzgerald Near Pivotal Inflection Point
-
Adani Power Limited (ADANI:IN) PT Lowered to INR244 at Cantor Fitzgerald as Swing Factor of Monsoon Approaches
-
Cantor Fitzgerald Starts Electra (ETRA) at Overweight
-
Cantor Fitzgerald Starts AIR Global (AIIR) at Overweight
-
Shopify gains as Cantor Fitzgerald hikes price target
-
MasTec (MTZ) Reiterated at Overweight by Cantor Fitzgerald Into Earnings
-
Rivian (RIVN) Reiterated at Neutral by Cantor Fitzgerald
-
Kodiak AI (KDK) Reiterated at Overweight by Cantor Fitzgerald - Moving Towards Long-Haul Driverless Launch in Q4
-
Lucid Group (LCID) Reiterated at Neutral by Cantor Fitzgerald as Bolt Targets Initial Fleet of ~25K Units
-
Vaxcyte (PCVX) PT Set at $120 at Cantor Fitzgerald - Pressure on Shares Explained by Challenging Market
-
Merck (MRK) Reiterated at Neutral by Cantor Fitzgerald
-
Zscaler (ZS) PT Raised to $275 at Cantor Fitzgerald on Stronger Conviction in AI-Driven Demand
-
SailPoint (SAIL)PT Raised to $27 by Cantor Fitzgerald
-
Form N-2/A Cantor Fitzgerald Energy
-
Molina Healthcare (MOH) Reiterated at Neutral by Cantor Fitzgerald
-
Humana (HUM) Reiterated at Overweight by Cantor Fitzgerald
-
Elevance (ELV) Reiterated at Overweight by Cantor Fitzgerald
-
CVS Health (CVS) Reiterated at Overweight by Cantor Fitzgerald
-
Centene (CNC) Reiterated at Overweight by Cantor Fitzgerald
-
Polestar Automotive Holding (PSNY) Reiterated at Underweight by Cantor Fitzgerald
-
Dycom Industries (DY) Reiterated at Overweight by Cantor Fitzgerald
-
SailPoint (SAIL) PT Raised to $27 at Cantor Fitzgerald on Potential Addressable Market Expansion
-
Cantor Fitzgerald Starts Ovid Therapeutics Inc (OVID) at Overweight
-
Lapmaster Wolters and Precision Surfacing Solutions Secures Strategic Minority Investment from The Cynosure Group and Fernweh Group to Accelerate Growth
-
SEALSQ and WISeSat.Space to Showcase Root-to-Qubit-to-Space Stack at IQT Quantum+Ai Event in New York
-
Pfizer (PFE) PT Raised to $28 at Cantor Fitzgerald on Growing Sector Tailwinds
-
Merck (MRK) PT Raised to $145 at Cantor Fitzgerald - Outstanding ESMO Expected
-
Eli Lilly (LLY) PT Raised to $1,440 at Cantor Fitzgerald - Consensus Numbers Above Top-Line Guide
-
Bristol-Myers Squibb Co. (BMY) PT Lowered to $53 at Cantor Fitzgerald on Anticipated Milvexian Pressure
-
Amgen (AMGN) PT Raised to $440 at Cantor Fitzgerald - 'Now a Clear Consensus Long'
-
Abbvie (ABBV) PT Raised to $290 at Cantor Fitzgerald
-
Dyne Therapeutics (DYN) Reiterated at Overweight by Cantor Fitzgerald
-
Eupraxia Pharmaceuticals (EPRX) Reiterated at Overweight by Cantor Fitzgerald - 'Stock Remains Undervalued'
-
Arthur J. Gallagher (AJG) PT Lowered to $280 at Cantor Fitzgerald on Lower Rollover Revenues
-
Arch Capital (ACGL) PT Lowered to $105 at Cantor Fitzgerald Amid Mortgage Insurance Stock Deratings
-
Rocket Pharmaceuticals (RCKT) Reiterated at Overweight by Cantor Fitzgerald After Update on RP-A501


